...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Have a great Sunday, especially those of you like me that are celebrating Orthodox Easter ... As well as those of you who are also like me and mourning another Maple Leafs Game 7 exit ... Ugggh!

Sincerely,

George et al

Message: In the near term we will continue our multi-point approach to progressing our corporate commercial value. This approach involves aggressive explorator

In the near term we will continue our multi-point approach to progressing our corporate commercial value. This approach involves aggressive explorator

posted on Dec 06, 2019 08:30AM

In the near term we will continue our multi-point approach to progressing our corporate commercial value. This approach involves aggressive exploratory development of the following:

  • Breakthrough Therapy status filings, both FDA and EMA, over the next 90-120 days

  • SGLT2i partnering discussions, one has already been initiated, key patent already filed

  • Renal partnering discussions ASAP

  • Congestive Heart Failure partnering discussions ASAP, already initiated

  • Orphan partnering discussions initially focused on PAH and HIV only at this time. PAH enrollment has already commenced. HIV funding being derived from a yet to be named US based organization

  • MoCA partnering discussion in progres

Share
New Message
Please login to post a reply